362 related articles for article (PubMed ID: 3119552)
1. Comparative in-vitro activity of Ro 23-6240, a new trifluorinated quinolone.
Verbist L
J Antimicrob Chemother; 1987 Sep; 20(3):363-72. PubMed ID: 3119552
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
Arpi M; Gahrn-Hansen B; Søgaard P; Bentzon MW
Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):141-6. PubMed ID: 3473910
[TBL] [Abstract][Full Text] [Related]
3. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
King A; Phillips I
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
[TBL] [Abstract][Full Text] [Related]
4. [Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].
Habiyaremye I; Verbist L; Vandepitte J
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):800-4. PubMed ID: 3116489
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activity of RO 23-6240 (fleroxacin), a new 4-quinolone derivative.
Machka K; Braveny I
Eur J Clin Microbiol; 1987 Aug; 6(4):482-5. PubMed ID: 3117538
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of RO 23-6240 (AM-833): a new fluoroquinolone.
Fass RJ; Helsel VL
Diagn Microbiol Infect Dis; 1987 Apr; 6(4):293-9. PubMed ID: 3107872
[TBL] [Abstract][Full Text] [Related]
7. [In vitro activity of new quinolones against nonfermenters and references to sensitivity tests].
Grimm H
Infection; 1986; 14 Suppl 3():S191-5. PubMed ID: 3093387
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of aerobic gram-negative blood culture isolates to oxolinic acid, norfloxacin, ciprofloxacin, enoxacin, pefloxacin, ofloxacin and oxo-enoxacin.
Van der Auwera P
Infection; 1986; 14(3):142-4. PubMed ID: 2942489
[TBL] [Abstract][Full Text] [Related]
9. In-vitro selection of bacteria resistant to the 4-quinolone agents.
Limb DI; Dabbs DJ; Spencer RC
J Antimicrob Chemother; 1987 Jan; 19(1):65-71. PubMed ID: 3470281
[TBL] [Abstract][Full Text] [Related]
10. In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus.
Smith SM
Antimicrob Agents Chemother; 1986 Feb; 29(2):325-6. PubMed ID: 2940966
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628.
Barrett MS; Jones RN; Erwin ME; Johnson DM; Briggs BM
Diagn Microbiol Infect Dis; 1991; 14(5):389-401. PubMed ID: 1665774
[TBL] [Abstract][Full Text] [Related]
12. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
Bassey CM; Baltch AL; Smith RP
J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
[TBL] [Abstract][Full Text] [Related]
13. In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compounds.
Jones RN; Barrett MS; Erwin ME; Briggs BM; Johnson DM
Diagn Microbiol Infect Dis; 1991; 14(4):319-30. PubMed ID: 1909615
[TBL] [Abstract][Full Text] [Related]
14. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
McCarter YS; Mazens-Sullivan MF; Bartlett RC
Chemotherapy; 1992; 38(5):308-18. PubMed ID: 1337507
[TBL] [Abstract][Full Text] [Related]
15. In-vitro activity of newer quinolones against aerobic bacteria.
Auckenthaler R; Michéa-Hamzehpour M; Pechère JC
J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
[TBL] [Abstract][Full Text] [Related]
16. In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosis.
Berlin OG; Young LS; Bruckner DA
J Antimicrob Chemother; 1987 May; 19(5):611-5. PubMed ID: 3112095
[TBL] [Abstract][Full Text] [Related]
17. In-vitro activity of fleroxacin compared with three other quinolones.
Bremner DA; Dickie AS; Singh KP
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():19-23. PubMed ID: 3144536
[TBL] [Abstract][Full Text] [Related]
18. In vitro studies of fleroxacin (Ro 23-6240), a new trifluorinated quinolone derivative.
Digranes A; Benonisen E; Salveson A; Zahm F
Chemotherapy; 1988; 34(5):401-10. PubMed ID: 3141116
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of CI-934 compared with ciprofloxacin, enoxacin, norfloxacin, and vancomycin.
Floyd-Reising SA; Kelley SG; Hindler JA; Young LS
Diagn Microbiol Infect Dis; 1987 Apr; 6(4):301-6. PubMed ID: 3472704
[TBL] [Abstract][Full Text] [Related]
20. The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
Ridgway GL; O'Hare MD; Felmingham D; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(4):259-62. PubMed ID: 2941258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]